Citable company snapshot

TMO company facts in plain English

Server-rendered

Thermo Fisher Scientific's latest SEC-sourced 2026-03-28 period shows $11.01B in revenue and $1.65B in net income.

TMO company facts in plain English
MetricLatest periodLatest valuePrior valueYoY
xbrl:RevenueFromContractWithCustomerExcludingAssessedTaxMar 28, 2026$11.01B$12.21B-9.9%
xbrl:OperatingIncomeLossMar 28, 2026$1.86B$2.25B-17.4%
xbrl:NetIncomeLossMar 28, 2026$1.65B$1.96B-15.9%
xbrl:NetCashProvidedByUsedInOperatingActivitiesMar 28, 2026$1.19B$3.46B-65.5%
Free Cash Flow (computed)Mar 28, 2026$816.00M$2.99B-72.7%

Source: SEC EDGAR XBRL; period Mar 28, 2026; filed May 1, 2026; accession 0000097745-26-000092.

Continue research

Follow same-sector companies and source explainers connected to the overview view.

Browse Health Care